Cover Image
Market Research Report

Opioid-Induced Bowel Dysfunction (OBD or OIBD) Global Clinical Trials Review, H1, 2018

Published by GlobalData Product code 299744
Published Content info 47 Pages
Delivery time: 1-2 business days
Price
Back to Top
Opioid-Induced Bowel Dysfunction (OBD or OIBD) Global Clinical Trials Review, H1, 2018
Published: April 25, 2018 Content info: 47 Pages
Description

GlobalData's clinical trial report, "Opioid-Induced Bowel Dysfunction (OBD or OIBD) Global Clinical Trials Review, H1, 2018" provides an overview of Opioid-Induced Bowel Dysfunction (OBD or OIBD) clinical trials scenario. This report provides top line data relating to the clinical trials on Opioid-Induced Bowel Dysfunction (OBD or OIBD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
Product Code: GDHC4902CTIDB

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Opioid-Induced Bowel Dysfunction (OBD or OIBD) to Toxicology Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Opioid-Induced Bowel Dysfunction (OBD or OIBD) to Toxicology Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials 27
  • Prominent Drugs 28
  • Clinical Trial Profile Snapshots 29

Appendix 45

  • Abbreviations 45
  • Definitions 45
  • Research Methodology 46
  • Secondary Research 46
  • About GlobalData 47
  • Contact Us 47
  • Source 47

List of Tables

List of Tables

  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials by Region, 2018* 7
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 10
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, North America, Top Countries, 2018* 12
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 13
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 14
  • Proportion of Opioid-Induced Bowel Dysfunction (OBD or OIBD) to Toxicology Clinical Trials, G7 Countries (%), 2018* 15
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
  • Proportion of Opioid-Induced Bowel Dysfunction (OBD or OIBD) to Toxicology Clinical Trials, E7 Countries (%), 2018* 18
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials by Phase, 2018* 20
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 21
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 22
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 23
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 24
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 25
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 26
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 27
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 28

List of Figures

List of Figures

  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 10
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 14
  • Proportion of Opioid-Induced Bowel Dysfunction (OBD or OIBD) to Toxicology Clinical Trials, G7 Countries (%), 2018* 15
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
  • Proportion of Opioid-Induced Bowel Dysfunction (OBD or OIBD) to Toxicology Clinical Trials, E7 Countries (%), 2018* 18
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 20
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 21
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 22
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 23
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 24
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 25
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 26
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 27
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 28
  • GlobalData Methodology 46
Back to Top